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The role played by -helix 4 of the Bacillus thuringiensis toxin Cry1Aa in pore formation was investigated by
individually replacing each of its charged residues with either a neutral or an oppositely charged amino acid
by using site-directed mutagenesis. The majority of the resulting mutant proteins were considerably less toxic
to Manduca sexta larvae than Cry1Aa. Most mutants also had a considerably reduced ability to form pores in
midgut brush border membrane vesicles isolated from this insect, with the notable exception of those with
alterations at amino acid position 127 (R127N and R127E), located near the N-terminal end of the helix.
Introducing a negatively charged amino acid near the C-terminal end of the helix (T142D and T143D), a region
normally devoid of charged residues, completely abolished pore formation. For each mutant that retained
detectable pore-forming activity, reduced membrane permeability to KCl was accompanied by an approxi-
mately equivalent reduction in permeability to N-methyl-D-glucamine hydrochloride, potassium gluconate,
sucrose, and raffinose and by a reduced rate of pore formation. These results indicate that the main effect of
the mutations was to decrease the toxin’s ability to form pores. They provide further evidence that -helix 4
plays a crucial role in the mechanism of pore formation.
Bacillus thuringiensis is the most extensively used commercial
biopesticide worldwide and is presently the sole source of toxin
genes for the development of insect-resistant transgenic plants
(13, 15, 42). The insecticidal activity of B. thuringiensis is pri-
marily associated with its ability to synthesize a crystalline
parasporal inclusion body containing highly specific insecti-
cidal proteins (22, 36). The mode of action of these insecticides
involves solubilization of the crystal in the highly alkaline lep-
idopteran midgut lumen, activation of the toxins by intestinal
proteases, recognition of one or more binding sites on the
midgut brush border membrane surface followed by pore for-
mation, and cell lysis leading ultimately to insect death (36).
The elucidation by X-ray diffraction analysis of the three-
dimensional structures of the activated Cry1Aa (21), Cry2Aa
(31), Cry3Aa (28), and Cry3Bb (16) toxins has revealed a
common three-domain folding pattern. Domain I is made of
seven -helices, and domains II and III are composed mostly
of -sheets. While domain I is considered to be responsible for
pore formation (37, 43, 44), domains II and III are involved in
receptor binding and host specificity (11, 12, 24, 47). Domain
III is also thought to play a role in protein stability (28). The
domains of the activated toxins were shown to interact with
each other to yield their overall toxic effect (33, 34). Exchang-
ing domain I from different toxins can affect crystal formation,
stability, pore formation, and membrane permeability as well
as the size of the pores and toxicity.
The toxin is thought to form pores in the cell membrane by
first inserting a hairpin composed of the hydrophobic 5 and
the amphipathic 4 helices (3, 30, 37). In agreement with this
mechanism, mutation analyses conducted on the various heli-
ces of domain I have shown that, except for a few specific
residues such as R93 in Cry1Ac (46) and R99 in Cry1Aa (41),
most alterations in 2 (46), 3 (23, 26, 41, 46), 6 (4), and 7
(1) result in relatively minor effects on toxin function, whereas
many of the single-site alterations introduced in 4 (2, 26, 30,
38) and 5 (32, 46) result in greatly reduced activity. Also
consistent with an important role of 4 and 5, synthetic pep-
tides corresponding to these helices (10, 17, 19) or to the
4-loop-5 segment (20) of Cry1Ac or Cry3Aa have been
shown to self-assemble and form ion channels in artificial lipid
bilayer membranes. In contrast, synthetic peptides correspond-
ing to 2, 3, 6, and 7 were found to bind to the surface of
the membrane (18).
In a previous study, mutations of 4-charged residues in
Cry1Aa were shown to considerably reduce toxicity to Plutella
xylostella and the conductance of the pores formed in receptor-
free planar lipid bilayers (30). In addition, chemical modifica-
tion of an engineered cysteine residue, D136C, has provided
strong evidence that 4 lines the lumen of the pore (30). More
recently, the 4 residue N135 of Cry1Ab and Cry1Ac was
shown to play a crucial role in toxin oligomerization and pore
formation (39). To further investigate the functional role of 4,
the pore-forming properties of mutants in which each charged
residue (R127, E128, E129, R131, and D136) in 4 was re-
placed individually with a neutral or an oppositely charged
amino acid were analyzed in brush border membrane vesicles
isolated from Manduca sexta by using an osmotic swelling per-
meability assay (6). Almost all of these mutations, as well as the
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replacement of neutral residues (T142 and T143) with aspartic
acid, resulted in substantial reductions in the toxicity and pore-
forming ability of the toxins.
MATERIALS AND METHODS
Mutagenesis. The mutations analyzed in the present study are listed in Table
1. They were introduced in 4 of Cry1Aa by in vitro site-directed mutagenesis
using the double oligonucleotide method (14) (Transformer kit; Clontech Lab-
oratories, Palo Alto, Calif.) and the double-stranded expression plasmid pMP39
(29). All mutants were sequenced using an Applied Biosystems (Foster City,
Calif.) model 370A automated fluorescent sequencer.
Toxin production and purification. All toxins were produced in Escherichia
coli grown at 30°C in double-strength YT broth containing 100 g of ampicil-
lin/ml (29). The insoluble protoxin-containing inclusions were harvested and
activated with 1% (wt/vol) trypsin as described previously (29). Activated toxins
were purified by fast protein liquid chromatography using a Mono Q ion ex-
change column (Pharmacia Biotech, Montreal, Canada) as described elsewhere
(29). Toxin purity and integrity were verified by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (27), and protein concentrations were determined
by the method of Bradford (5) with bovine serum albumin as a standard.
Bioassays. Fertilized eggs of M. sexta were purchased from the Carolina
Biological Supply Company (Burlington, N.C.). Toxicity assays were performed
on artificial diet (8) as described previously (41) using neonate larvae and
trypsin-activated toxins. Mortality was recorded after 7 days. All mutant toxins
were tested at 2 g/ml, and, depending on the percent mortality observed at this
concentration, the tests were repeated at either 50 ng/ml or 50 g/ml. Thirty
larvae were used for each toxin concentration tested, and the bioassays were
replicated five times.
Preparation of brush border membrane vesicles. M. sexta larvae were raised to
the fifth instar on the artificial diet supplied with the insects. Whole midguts were
isolated, cleared of their contents and attached Malpighian tubules, and stored at
80°C until use. Brush border membrane vesicles were prepared from thawed
midguts as described previously (41) using a magnesium precipitation and dif-
ferential centrifugation method (45).
Light-scattering assay. Brush border membrane permeability was analyzed
with a light-scattering assay as described by Carroll and Ellar (6). Osmotic
volume changes were monitored by measuring the 90° scattered light intensity at
23°C in a Spex CMIII spectrofluorometer (Jobin Yvon Horiba, Edison, N.J.)
with both monochromators set at 450 nm. To test whether the mutations altered
the properties of the pores, membrane permeability was measured in the pres-
ence of 150 mM KCl, the chloride salt of the relatively large cation N-methyl-
D-glucamine, the potassium salt of the relatively large anion gluconate, or 300
mM disaccharide sucrose or trisaccharide raffinose. A mutation affecting mainly
the number of pores formed would alter membrane permeability to all solutes,
relative to that observed with Cry1Aa, to a similar extent. On the other hand, an
alteration in pore size is expected to mainly affect membrane permeability to the
larger solutes. Finally, a change in ionic selectivity of the pores would result in a
stronger effect on the permeability to N-methyl-D-glucamine or to gluconate. To
evaluate the ability of the toxins to permeabilize the membrane to these various
solutes, vesicles were preincubated for 60 min with the selected concentration of
toxin before the light-scattering assays were performed as described previously
(9, 41). In kinetic experiments designed to estimate the rate at which the toxins
increase membrane permeability, vesicles were exposed to the toxin at the onset
of the light-scattering experiments as described previously (9, 41).
Data analysis. Percent volume recovery was calculated as 100(1  It), where
It is the relative scattered light intensity measured at time t. For kinetic experi-
ments, percent volume recovery was calculated for each data point and values
obtained for control vesicles, assayed without toxin, were subtracted from the
experimental values measured in the presence of toxin. The ascending portion of
each resulting trace was best fitted with a Boltzmann sigmoid using the Origin
version 6.1 program (OriginLab Corp., Northampton, Mass.). The delay preced-
ing vesicle swelling, arbitrarily defined as the time required to reach a percent
volume recovery of 5%, was derived directly from these fitted curves. The
maximal rate of osmotic swelling was obtained for each trace as the peak value
of the first derivative of the sigmoidal fit. Data are reported as means standard
errors of the means (SEM) of at least three experiments performed with different
vesicle preparations. Experimental values for each individual experiment con-
sisted of the average of five replicates obtained using the same vesicle prepara-
tion. Statistical comparisons were made with the two-tailed unpaired t test using
the Instat version 1.13 program (Graphpad Software, San Diego, Calif.).
RESULTS
Toxicity. Cry1Aa has five charged amino acids in 4, two
positively charged ones (R127 and R131) and three negatively
charged ones (E128, E129, and D136). The respective position
of these amino acids within 4 is shown in Fig. 1. These
charged residues are all located on the same side, covering a
little more than half of the circumference of the helix, which
comprises 10 polar residues out of a total of 17. The other side
of the helix has nine residues, including a single polar amino
acid (Q133). Most mutants were considerably less toxic to M.
sexta larvae than Cry1Aa (Table 1). At 2 g of toxin/ml, only
five mutants, R127E, R127N, E128C, R131E, and R131Q,
were lethal to more than 10% of the larvae. At 50 ng of toxin/
ml, mortality levels observed for R127N and E128C were
about twofold lower than those observed for wild-type Cry1Aa,
while R127E, R131E, and R131Q caused approximately six- to
sevenfold less mortality than Cry1Aa. The least toxic mutants
were E129K, R131H, D136C, and D136Y, for which mortali-
ties below 10% were observed at 50 g of toxin/ml.
FIG. 1. Amino acid sequence and helical wheel representation of
4 from Cry1Aa. Charged residues, in which mutations were intro-
duced, are identified by boldface.
TABLE 1. Toxicity of Cry1Aa 4 mutants toward M. sexta larvae
Toxin
% Mortalitya at:
50 ng/ml 2 g/ml 50 g/ml
Cry1Aa 45  1 —b —
R127E 6  1 89  2 —
R127N 22  1 97  1 —
E128C 24  3 92  2 —
E129C — 7  2 14  2
E129K — 7  2 8  1
R131D — 8  1 23  2
R131E 7  2 92  1 —
R131H — 6  2 7  2
R131Q 7  1 33  1 95  2
D136C — 7  1 9  1
D136N — 6  2 17  1
D136Y — 5  2 8  2
T142D — 5  2 23  1
T143D – 10  1 21  1
a Values are means  SEM of five independent experiments.
b —, not tested.
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Pore-forming ability. The pore-forming properties of these
mutants were analyzed with an osmotic swelling assay (6). In
this assay, permeability to a given solute is evaluated by mea-
suring scattered light intensity following rapid mixing of the
vesicles with a hypertonic solution of the solute. The ensuing
osmotic shrinking of the vesicles is detected by a rapid rise in
scattered light intensity (Fig. 2). As the solute diffuses into the
vesicles, these swell at a rate and to an extent that depend on
the permeability of the membrane to the solute. Membrane
permeability increases rapidly with increasing concentration of
an active toxin, as illustrated by R127N, the mutant with the
highest toxicity, and among those with the strongest pore-
forming ability (Fig. 2A). In contrast, with an inactive mutant,
such as E129K, the vesicle-swelling rate was identical to that
observed with control vesicles and was independent of toxin
concentration (Fig. 2B).
The highly alkaline conditions, characteristic of the lepidop-
teran midgut lumen, are thought to play an important role in B.
thuringiensis toxin function (36). The pore-forming ability of
some toxins, including Cry1C (40) and several Cry1Aa 3
mutants (41), has indeed been shown to be strongly modulated
by pH. Experiments were therefore carried out at both pH 7.5
and 10.5. Altering charged residues within 4 caused drastic
reductions in the pore-forming ability of most mutant toxins
(Fig. 3), with the exception of R127E, R127N (Fig. 3A and B),
and R131H (Fig. 3G and H), as well as R131D at pH 7.5 (Fig.
3G). The most dramatic losses of activity were observed for
E129C, E129K (Fig. 3E and F), and D136Y (Fig. 3I and J). In
addition, introducing a negatively charged aspartic acid in
T142D and T143D, near the C-terminal end of the helix, which
is normally devoid of charged residues, resulted in a complete
loss of activity (Fig. 3K and L). Increasing pH from 7.5 to 10.5
had little effect on the inactive mutants or on Cry1Aa, R127E,
or R127N (Fig. 3A and B), but considerably reduced activity
was observed at the higher pH for all mutants with alterations
at position 131, except for R131H (Fig. 3G and H). In contrast,
vesicle permeability to KCl was higher at pH 10.5 than at pH
7.5 in the presence of E128C (Fig. 3C and D) and D136C (Fig.
3I and J).
Kinetics of pore formation. All mutants that retained a de-
tectable pore-forming ability according to the preincubation
assay results (Fig. 3) were further tested to evaluate the rate at
which they increased membrane permeability. This increase
was measured by monitoring percent volume recovery as a
function of time after exposing the vesicles simultaneously to
the toxin and to a KCl gradient (Fig. 4). In the presence of an
active toxin, the resulting traces are characterized by a sigmoi-
dal increase in percent volume recovery. Two kinetic parame-
ters were derived from Boltzmann sigmoidal curves fitted to
each experimental trace: the delay preceding the time at which
percent volume recovery reached 5% and the maximal rate of
increase in percent volume recovery, corresponding to the
slope of the curves at their inflection point and determined as
the peak value of the first derivative of the fitted curves (Table
2). In agreement with their strong pore-forming ability follow-
ing a 1-h preincubation with the vesicles (Fig. 3), R127E and
R127N were the most active among the mutants tested, dis-
playing the shortest delays and highest vesicle-swelling rates.
Nevertheless, R127E had significantly less activity than Cry1Aa
and R127N in the kinetic assay, especially at pH 10.5 (Fig. 4),
which correlated well with its lower toxicity (Table 1). The
other mutants were all significantly less active than Cry1Aa,
with more than threefold longer delays and more than fourfold
lower rates of vesicle swelling (Table 2). Except for E128C,
D136C, D136N, and Cry1Aa, all toxins permeabilized the
membrane after a significantly longer delay (P  0.01) and
at a significantly lower rate (P  0.01) at pH 10.5 than at pH
7.5.
Pore properties. The properties of the pores formed by the
various active mutants were further investigated by measuring
their permeability to the large uncharged solutes, sucrose and
raffinose (Fig. 5), and to the large ions, N-methyl-D-glucamine
and gluconate (Fig. 6). As expected from its smaller size, su-
crose diffused faster than raffinose across the pores formed by
the toxins. In agreement with their higher permeability to KCl
(Fig. 3), the pores formed by R127E, R127N, and R131H
displayed a higher permeability to sucrose (Fig. 5A and B) and
raffinose (Fig. 5C and D) than those formed by all of the other
mutants. At variance with the KCl permeability data (Fig. 3),
however, the pores formed by R131D were significantly less
permeable than those formed by Cry1Aa to both sugars. Those
FIG. 2. Effect of 4 mutants on the osmotic swelling of M. sexta
brush border membrane vesicles. Midgut membrane vesicles isolated
from fifth-instar M. sexta larvae and equilibrated overnight in 10 mM
HEPES-KOH (pH 7.5) were preincubated for 60 min with the indi-
cated concentrations (in picomoles of toxin/milligram of membrane
protein) of either R127N (A) or E129K (B). Vesicles were rapidly
mixed with an equal volume of 150 mM KCl and 10 mM HEPES-KOH
(pH 7.5) directly in a cuvette using a stopped-flow apparatus. Each
trace corresponds to the average of five experiments.
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formed by R131H were also significantly less permeable to
sucrose at pH 7.5 and to raffinose at pH 10.5. The pores
formed by Cry1Aa and Cry1Ac have previously been shown to
be more permeable to sucrose at pH 10.5 than at pH 7.5, sug-
gesting a slightly larger pore diameter at the higher pH (7, 9,
40, 41). Although higher permeabilities to sucrose were ob-
served at pH 10.5, with most mutants capable of forming pores
at both pH values, none of these increases was statistically
significant (P  0.05).
In agreement with the fact that the pores formed by B. thur-
ingiensis toxins are generally cation selective, higher osmotic
swelling rates were observed in the presence of N-methyl-D-
glucamine hydrochloride (Fig. 6A) than with potassium glu-
conate (Fig. 6B and C) (25). Because N-methyl-D-glucamine is
not ionized at pH 10.5, experiments with this compound were
only conducted at pH 7.5. As was observed with the other sol-
utes, membrane permeability to both N-methyl-D-glucamine
hydrochloride and potassium gluconate in the presence of
R127E, R127N, or R131H was similar to that observed with
Cry1Aa, although the pores formed by R127N were signifi-
cantly more permeable to N-methyl-D-glucamine (P  0.05)
than those formed by Cry1Aa (Fig. 6A) and those formed by
R131H were significantly less permeable to potassium glu-
conate at pH 7.5 (Fig. 6B). The pores formed by all other mu-
tants were significantly less permeable to both solutes than
those formed by Cry1Aa.
DISCUSSION
The results of the present study confirm and extend a pre-
vious demonstration that most mutations altering charged res-
idues of 4 result in strong reductions in the toxicity and
pore-forming properties of Cry1Aa (30). Although the larvae
of M. sexta were more sensitive to Cry1Aa than those of P. xy-
lostella (studied previously), E129K, R131D, R131Q, D136C,
and D136N were poorly toxic, and R127N was only slightly less
toxic than the wild-type toxin, for both species. However, al-
though R127E and R127N displayed a similar toxicity to P. xy-
lostella, the former mutant was less toxic than the latter to
M. sexta. With the exception of E128C and R131E, the addi-
tional mutants with charge alterations or additions in 4 resi-
dues included in the present study, E129C, R131H, D136Y,
T142D, and T143D, were all essentially nontoxic to M. sexta
larvae. Charge alterations in 4 residues that reduce the tox-
icity of other B. thuringiensis toxins include R131L and Q133R
from Cry1Ac (26), R158A from Cry4Ba (38), and K123A,
R136A, R136D, R136K, R136Q, and E141A from Cry11A (2).
However, other mutations altering 4 charged residues, in-
cluding R131C and R131S, had no significant effect on the
toxicity of Cry1Ac (26), nor did R143A and E159A affect that
of Cry4Ba (38).
The mutants E129K, D136C, and D136N have been previ-
ously shown to be considerably less active than Cry1Aa in
FIG. 3. Pore-forming ability of 4 mutants. Brush border membrane vesicles equilibrated overnight in 10 mM either HEPES-KOH (pH 7.5)
(A, C, E, G, I, and K) or CAPS (3-cyclohexylamino-1-propanesulfonic acid)-KOH (pH 10.5) (B, D, F, H, J, and L) were preincubated for 60 min
with the indicated concentrations of either Cry1Aa or one of its mutants with alterations at amino acid positions 127 (A and B), 128 (C and D),
129 (E and F), 131 (G and H), 136 (I and J), or 142 and 143 (K and L). Their permeability to KCl was monitored following rapid mixing with 150
mM KCl and 10 mM either HEPES-KOH (pH 7.5) (A, C, E, G, I, and K) or CAPS-KOH (pH 10.5) (B, D, F, H, J, and L). Percent volume recovery
was calculated for the 3-s time point from traces like those shown in Fig. 2. Data are means  SEM of at least three independent experiments.
Asterisks indicate statistically significant differences with the corresponding values obtained for wild-type Cry1Aa (*, P  0.05; **, P  0.01).
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planar lipid bilayer experiments (30). While lipid bilayer stud-
ies allow a detailed analysis of the properties of the pores at
the single-channel level, osmotic swelling experiments, such as
those presented herein, are better suited for characterizing
overall toxin pore-forming ability and rates of pore formation.
In addition, these experiments were carried out using vesicles
prepared from the midgut brush border membrane, which con-
stitutes the natural target of these toxins and therefore pos-
sesses the toxin receptors of the insect species from which it
was isolated. Our choice of M. sexta for the present study was
motivated by the fact that large quantities of tightly sealed and
osmotically active vesicles can be prepared with much greater
ease from this species than from small insects such as P. xylo-
stella. This choice also has the advantage of allowing a direct
comparison with previous studies using the same experimental
system and in which mutations were introduced elsewhere in
Cry1Aa (9, 41).
For most of the mutants, losses in toxicity correlated well
with significant reductions in pore-forming ability and reduced
rates of pore formation. The only exceptions were E128C and
R131E, which retained a relatively strong toxicity despite a
significantly reduced pore-forming ability, and R131H and
R131D, which were poorly toxic but displayed a pore-forming
ability that was comparable to that of Cry1Aa, although R131D
completely lost its capacity to form pores at pH 10.5. Examples
of toxins with poor toxicity that readily form pores in brush
border membrane vesicles have been reported previously (9,
40, 41). Although such differences between in vivo and in vitro
toxin activities require further study, they are probably attrib-
utable to reduced toxin stability in the presence of midgut
proteases and emulsifying agents. E128C and R131E, however,
appear to be stable enough to kill insect larvae even though
they form pores significantly less efficiently than Cry1Aa during
the much smaller time frame of the in vitro experiments.
Interestingly, R131D was significantly more active than
R131E at pH 7.5 in the osmotic swelling assay, despite the fact
that these two toxins differ by a single methylene group. This
result indicates that the deleterious effect of inverting the pos-
itive charge at this position is amplified by increasing the length
of the side chain of the negatively charged amino acid. The
effect of this charge alteration was greatly amplified at pH 10.5,
at which both toxins were completely inactive. This suggests an
unfavorable interaction of the negative charge with one or
more amino acid residues that are titrated between pH 7.5 and
10.5, such as lysine and tyrosine. The involvement of a lysine
residue appears unlikely because the activated Cry1Aa has only
two such residues, both in domain III. On the other hand, 11
tyrosine residues are present in domain I, scattered among all
helices except 2 and 4. At variance with these in vitro data,
however, R131E was more toxic to the larvae than R131D,
even though both toxins were considerably less toxic than wild-
type Cry1Aa. Additional factors, possibly including ionic strength
and the presence of a strong membrane potential, thus appear
to modulate toxin activity as was suggested previously (40).
Toxin-induced membrane permeability depends not only on
the efficiency with which pores are formed within the mem-
FIG. 4. Kinetics of pore formation. Brush border membrane vesi-
cles equilibrated overnight in 10 mM either HEPES-KOH (pH 7.5)
(A) or CAPS (3-cyclohexylamino-1-propanesulfonic acid)-KOH (pH
10.5) (B) were mixed with an equal volume of 150 mM KCl and 10 mM
either HEPES-KOH (pH 7.5) (A) or CAPS-KOH (pH 10.5) (B) and
150 pmol of toxin/mg of membrane protein of Cry1Aa, R127E, or
R127N, without preincubation. Percent volume recovery was calcu-
lated for each experimental point, and control values were subtracted
from those obtained in the presence of toxin. For clarity, error bars
(SEM) are shown only for every 50th data point.
TABLE 2. Kinetics of pore formation by Cry1Aa 4 mutants
in M. sexta midgut brush border membrane vesicles
Toxin
Delaya (min) Swelling rate
b
(% vol recovery/min)
pH 7.5 pH 10.5 pH 7.5 pH 10.5
Cry1Aa 0.45  0.03 0.57  0.04 26.7  3.3 23.5  1.8
R127E 0.64  0.02**c 1.33  0.13** 15.4  0.3 6.6  0.7**
R127N 0.38  0.03 0.58  0.02 30.1  1.9 19.3  0.9
E128C 3.06  0.40** 4.01  0.22** 2.7  0.3** 2.0  0.2**
R131D 1.35  0.15** NAd 6.2  0.5** NA
R131E 1.42  0.20** NA 6.2  0.8** NA
R131H 1.61  0.24** 6.00 6.7  0.6** 0.4  0.3**
R131Q 2.24  0.32** NA 3.5  0.6** NA
D136C 2.89  0.56** 1.84  0.22** 4.1  0.4** 5.4  0.9**
D136N 2.03  0.26** 3.17  0.42** 4.5  0.1** 3.0  0.8**
a Time required for volume recovery to reach 5%.
b Slope at the inflection point of the Boltzmann sigmoidal curves fitted to the
data points.
c **, Significantly different from the corresponding value obtained for Cry1Aa
(P  0.01).
d NA, not active at pH 10.5.
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brane but also on the biophysical properties of the pores, in-
cluding their diameter and ion selectivity. To evaluate the
possible effect of the mutations on these parameters, all mu-
tants that retained a detectable pore-forming ability with KCl
were tested for their capacity to permeabilize the membrane
to relatively large solutes which included both neutral and
charged species. For most mutants, permeability to each of
these solutes was affected to an extent which closely paralleled
that observed with KCl. This clearly indicates that the major
effect of most mutations analyzed was a substantial reduction
in the ability of the toxins to form functional pores. Possible
exceptions include R131D which, even though it was not func-
tional at pH 10.5, displayed a permeability to KCl at pH 7.5
which was similar to that observed with Cry1Aa but was sig-
nificantly lower to each of the larger solutes. In the presence of
R131H, permeability to KCl was similar to that observed with
Cry1Aa at both pH values, but permeability to sucrose and
potassium gluconate at pH 7.5 and to raffinose at pH 10.5 was
significantly lower. These results suggest that R131D and
R131H could form pores with a somewhat smaller diameter
than those formed by Cry1Aa.
Changes in pH strongly affect the pore-forming ability of
certain B. thuringiensis toxins, such as Cry1C, while having only
minor effects on the activity of others, such as Cry1Ac (40). In
the present study, Cry1Aa and most of its mutants were not
significantly affected by this factor in the preincubation assays,
even though almost all mutants were less active at the higher
pH in the kinetic assay. Increasing pH from 7.5 to 10.5, how-
ever, completely abolished the ability of R131D, R131E, and
R131Q to form pores. A few cases of Cry1Aa mutants that
formed pores less efficiently at the higher pH have been re-
ported earlier (41). In contrast, E128C and D136C were sig-
nificantly more active at pH 10.5 than at pH 7.5. The thiol
group of cysteine has a pKa of 8.3 (35). This increase in toxin
activity therefore coincides with the restoration of the negative
charge normally present at these positions in the wild-type
toxin. Such pH-dependent increases in toxin activity have not
been observed in other cases where a negatively charged amino
acid was replaced by a cysteine, including the 3 mutants
E101C and E118C (41) and the 4 mutant E129C. These
findings suggest that a negative charge on residues 128 and 136
contributes significantly to the activity of Cry1Aa, even though
the sole presence of a negative charge at these positions was
clearly insufficient to restore the toxin’s full activity. These
results are also consistent with earlier demonstrations that the
thiol group of D136C is accessible to chemical modification
within the lumen of the pore and that adding a negative charge
to this residue in situ results in a substantially increased con-
ductance and probability the pores will be open (30). The fact
that pH affects the activity of E128C and D136C in a similar
FIG. 5. Effect of 4 mutants on vesicle permeability to oligosaccharides. Vesicles equilibrated in 10 mM either HEPES-KOH (pH 7.5) (A and
C) or CAPS (3-cyclohexylamino-1-propanesulfonic acid)-KOH (pH 10.5) (B and D) were preincubated for 60 min with 150 pmol of toxin/mg of
membrane protein. Their permeability to sucrose (A and B) and raffinose (C and D) was monitored following rapid mixing with 300 mM either
sucrose or raffinose and 10 mM either HEPES-KOH (pH 7.5) (A and C) or CAPS-KOH (pH 10.5) (B and D) as described in the legends of Fig.
2 and 3. Asterisks indicate statistically significant differences with Cry1Aa (*, P  0.05; **, P  0.01).
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manner suggests that the negative charge on E128 plays an
important role in the formation of functional pores, possibly by
ensuring that a high proportion of the channels are in their
open state. Alternatively, this residue could be involved in the
oligomerization of the toxin, as suggested by its close proximity
with N135, which has been clearly shown to be essential for this
aspect of pore formation (39).
In conclusion, our results, along with those of previous stud-
ies (2, 26, 30, 38, 39), provide further evidence that the func-
tional properties of B. thuringiensis toxins are strongly influ-
enced by mutations altering 4 residues. They also indicate
that this helix is critically involved not only in the architecture
of the pores (30) but also in the mechanism by which toxin
molecules insert into the membrane to form a functional pore.
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